BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 30479091)

  • 1. Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma.
    Yoneoka Y; Yoshida H; Ishikawa M; Shimizu H; Uehara T; Murakami T; Kato T
    J Gynecol Oncol; 2019 Jan; 30(1):e7. PubMed ID: 30479091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
    Ma SK; Zhang HT; Sun YC; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
    Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
    Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
    Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
    [No Abstract]   [Full Text] [Related]  

  • 5. Synchronous endometrial and ovarian carcinomas: predictors of risk and associations with survival and tumor expression profiles.
    Kelemen LE; Rambau PF; Koziak JM; Steed H; Köbel M
    Cancer Causes Control; 2017 May; 28(5):447-457. PubMed ID: 28194593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic characteristics and outcomes of endometrial Cancer patients with mismatch repair deficiency in the era of universal Lynch syndrome screening.
    Carr C; Son J; Yao M; Priyadarshini A; Marquard J; Vargas R; Michener C; AlHilli MM
    Gynecol Oncol; 2020 Dec; 159(3):712-720. PubMed ID: 33046272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.
    Bosse T; Peters EE; Creutzberg CL; Jürgenliemk-Schulz IM; Jobsen JJ; Mens JW; Lutgens LC; van der Steen-Banasik EM; Smit VT; Nout RA
    Eur J Cancer; 2015 Sep; 51(13):1742-50. PubMed ID: 26049688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synchronous primary ovarian and endometrial cancer with a fair prognosis in a young woman.
    Yang YH; Chen RJ; Lin MC; Cheng SP; Chang TC
    Taiwan J Obstet Gynecol; 2010 Mar; 49(1):97-100. PubMed ID: 20466303
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
    Zhu J; Wen H; Bi R; Wu X
    J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synchronous dual primary ovarian and endometrial carcinomas.
    Pearl ML; Johnston CM; Frank TS; Roberts JA
    Int J Gynaecol Obstet; 1993 Dec; 43(3):305-12. PubMed ID: 7907042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-based stratification of carcinomas concurrently involving the endometrium and ovary.
    Turashvili G; Gómez-Hidalgo NR; Flynn J; Gonen M; Leitao MM; Soslow RA; Murali R
    Gynecol Oncol; 2019 Jan; 152(1):38-45. PubMed ID: 30413340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression Free Survival, Overall Survival, and Relapse Rate in Endometrioid Ovarian Cancer and Synchronous Endometrial-Ovarian Endometrioid Cancer (SEO-EC): Results from a Large Retrospective Analysis.
    Pecorino B; Laganà AS; Chiantera V; Ferrara M; Di Stefano AB; Di Donna MC; Sorrentino F; Nappi L; Mikuš M; Scollo P
    Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556908
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinicopathologic variables and survival comparison of patients with synchronous endometrial and ovarian cancers versus primary endometrial cancer with ovarian metastasis.
    Oranratanaphan S; Manchana T; Sirisabya N
    Asian Pac J Cancer Prev; 2008; 9(3):403-7. PubMed ID: 18990010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence patterns and prognostic factors in lymphovascular space invasion-positive endometrioid endometrial cancer surgically confined to the uterus.
    Sahin H; Meydanli MM; Sari ME; Kocaman E; Cuylan ZF; Yalcin I; Coban G; Özen Ö; Sirvan L; Güngör T; Ayhan A
    Taiwan J Obstet Gynecol; 2019 Jan; 58(1):82-89. PubMed ID: 30638487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic analysis with immunohistochemistry for DNA mismatch repair protein expression in synchronous primary endometrial and ovarian cancers.
    Kobayashi Y; Nakamura K; Nomura H; Banno K; Irie H; Adachi M; Iida M; Umene K; Nogami Y; Masuda K; Kisu I; Ueki A; Yamagami W; Kataoka F; Hirasawa A; Tominaga E; Susumu N; Aoki D
    Int J Gynecol Cancer; 2015 Mar; 25(3):440-6. PubMed ID: 25695547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does MMR status in endometrial cancer influence response to adjuvant therapy?
    Kim SR; Pina A; Albert A; McAlpine J; Wolber R; Blake Gilks C; Kwon JS
    Gynecol Oncol; 2018 Oct; 151(1):76-81. PubMed ID: 30172479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique prognostic features of grade 3 endometrioid endometrial carcinoma: Findings from 101 consecutive cases at a Japanese tertiary cancer center.
    Kato MK; Yoshida H; Uehara T; Uno M; Ishikawa M; Miyasaka N; Kato T
    Taiwan J Obstet Gynecol; 2021 Mar; 60(2):238-244. PubMed ID: 33678322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Adjuvant Modalities on Survival in Patients with Advanced Stage Endometrial Carcinoma: A Retrospective Analysis from a Tertiary Medical Center.
    Tai YJ; Hsu HC; Chiang YC; Chen YL; Chen CA; Cheng WF
    Int J Environ Res Public Health; 2019 Jul; 16(14):. PubMed ID: 31323767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L1CAM expression associates with poor outcome in endometrioid, but not in clear cell ovarian carcinoma.
    Soovares P; Pasanen A; Bützow R; Lassus H
    Gynecol Oncol; 2017 Sep; 146(3):615-622. PubMed ID: 28625395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
    Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
    Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.